Superheavy element
Superheavy elements are chemical elements with atomic numbers greater than 104, extending beyond the actinide series into the transactinide series and further. These elements occupy the end of the Periodic Table, in the seventh period. Due to their extremely high atomic numbers, all superheavy elements are synthetic and are created in particle accelerators through the fusion of lighter elements. They have very short half-lives, with many existing for only fractions of a second before decaying into lighter elements through a series of radioactive decays.
Discovery and Synthesis
The quest to discover superheavy elements has been driven by the desire to explore the limits of the periodic table and the properties of matter under extreme nuclear conditions. The first superheavy element, Rutherfordium (element 104), was synthesized in the 1960s. Since then, research teams, particularly those at the Joint Institute for Nuclear Research in Dubna, Russia, and the Lawrence Berkeley National Laboratory in the United States, have competed and collaborated in the discovery of new elements.
The synthesis of superheavy elements is achieved by bombarding target atoms of one element with ions of another in a particle accelerator. This process, known as nuclear fusion, must overcome the immense Coulomb Barrier that repels the positively charged nuclei from each other. The successful fusion results in the formation of a superheavy element, which is then identified by its decay products.
Properties and Stability
Superheavy elements are of particular interest due to their predicted island of stability. This theoretical concept suggests that certain superheavy nuclei with specific numbers of protons and neutrons (magic numbers) will have significantly longer half-lives, making them more stable than surrounding isotopes. While elements up to oganesson (element 118) have been synthesized, the island of stability, expected to center around elements with atomic numbers 114 to 120 and neutron numbers around 184, remains largely unexplored.
The chemical properties of superheavy elements are challenging to study due to their short half-lives and the tiny amounts in which they are produced. However, theoretical and experimental work suggests that relativistic effects may significantly influence their chemical behavior, potentially leading to deviations from the periodic trends observed in lighter elements.
Future Research
Research into superheavy elements continues with the goals of synthesizing new elements, exploring the island of stability, and understanding the effects of extreme nuclear charge on chemical properties. Future discoveries will rely on advances in accelerator technology and detection methods, as well as international collaboration among scientists in the field.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD